QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, May 6, 2009, 29(18):6007-6012; doi:10.1523/JNEUROSCI.5346-08.2009

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Michaluk, P. Articles by Kaczmarek, L. Search for Related Content PubMed PubMed Citation Articles by Michaluk, P. Articles by Kaczmarek, L.

 Previous Article  |  Next Article 

Brief Communications
Matrix Metalloproteinase-9 Controls NMDA Receptor Surface Diffusion through Integrin β1 Signaling

Piotr Michaluk,^1,2 Lenka Mikasova,³ Laurent Groc,³ Renato Frischknecht,⁴ Daniel Choquet,³ and Leszek Kaczmarek¹

¹The Nencki Institute, 02-093 Warsaw, Poland, ²University Medical Center, 3584 CG Utrecht, The Netherlands, ³Unité Mixte de Recherche 5091, Centre National de la Recherche Scientifique, Université Bordeaux 2, 33077 Bordeaux, France, and ⁴Leibniz Institute for Neurobiology, D-39118 Magdeburg, Germany

Correspondence should be addressed to Leszek Kaczmarek, The Nencki Institute, Pasteur 3, 02-093 Warsaw, Poland. Email: l.kaczmarek{at}nencki.gov.pl

Matrix metalloproteinase-9 (MMP-9) has emerged as a physiological regulator of NMDA receptor (NMDAR)-dependent synaptic plasticity and memory. The pathways by which MMP-9 affects NMDAR signaling remain, however, elusive. Using single quantum dot tracking, we demonstrate that MMP-9 enzymatic activity increases NR1-NMDAR surface trafficking but has no influence on AMPA receptor mobility. The mechanism of MMP-9 action on NMDAR is not mediated by change in overall extracellular matrix structure nor by direct cleavage of NMDAR subunits, but rather through an integrin β1-dependent pathway. These findings describe a new target pathway for MMP-9 action in key physiological and pathological brain processes.

---

Received Nov. 6, 2008; revised March 23, 2009; accepted March 27, 2009.

Correspondence should be addressed to Leszek Kaczmarek, The Nencki Institute, Pasteur 3, 02-093 Warsaw, Poland. Email: l.kaczmarek{at}nencki.gov.pl

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help